Want to join the conversation?
In 3Q15, $ABT achieved a double digit organic growth in emerging markets led predominantly by Nutrition business and supported by branded generics and diagnostics. Like arch rivals $BSX and $AMGN, $ABT too facing FX challenges. Despite the slowdown and other challenges, $ABT reported 10.9% hike in worldwide sales.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.